MedTrace Logo

Web-based Genetic Research on Lupus

NCT02530944 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 5000

Last updated 2018-01-10

No results posted yet for this study

Summary

The goal of this new lupus research study is two-fold: first, to understand the genetic associations found between people's DNA and this disease, and second, to apply this understanding to drug development efforts with the investigator's partners at Pfizer.

Conditions

Sponsors & Collaborators

  • Pfizer

    collaborator INDUSTRY

  • 23andMe, Inc.

    lead INDUSTRY

Eligibility

Min Age
6 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-05-31
Primary Completion
2017-10-31
Completion
2017-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02530944 on ClinicalTrials.gov